| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Oct 2018 - 31 Mar 2019 | 03 Oct 2019 | 32 | 68% | 11% | 21% | 7% |
| 01 Apr 2018 - 30 Sept 2018 | 30 Oct 2018 | 28 | 69% | 22% | 9% | 22% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The majority of suppliers are subject to local standard terms of purchase or qualify as small medium businesses and are subject to standard payment terms of 30 or 45 days from receipt of a valid invoice. Global and larger local suppliers with negotiated contracts are subject to standard payment terms of up to 90 days from receipt of a valid invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Disputes related to payment are generally resolved informally by discussion between the relevant parties
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Takeda Development Centre Europe Ltd is registered in England and Wales with a nature of business classified as research and experimental development on natural sciences and engineering. It shares its registered address with Takeda UK Limited and is listed separately as Takeda Development Centre Europe, indicating it operates as the research and development arm within the UK operations of the Takeda group, a global pharmaceutical company. The wider Takeda group, headquartered in the same London building, focuses on developing medicines and vaccines and employs over 300 people in the UK. This entity's role centres on scientific development activity supporting that group's pharmaceutical research, rather than commercial sales or manufacturing itself.
Generated from the company's website and Companies House records. Sources: takeda.co.uk